Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
about
A comparative public health and budget impact analysis of pneumococcal vaccines: The French casePneumococcal conjugate vaccines for adults: reasons for optimism and for caution.What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?The stubborn persistence of adult pneumococcal pneumonia as a public health problem.Preventing non bacteremic pneumococcal pneumonia in older adults: historical background and considerations for choosing between PCV13 and PPV23.
P2860
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@en
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@nl
type
label
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@en
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@nl
prefLabel
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@en
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@nl
P2860
P356
P1476
Pneumococcal conjugate vaccination for older adults: Reply letter to Hollingsworth et al.
@en
P2860
P356
10.4161/HV.26422
P577
2013-09-12T00:00:00Z